Dyne Therapeutics Inc (DYN) returns
Dyne Therapeutics returns over 5 years
$1,000 invested in Dyne Therapeutics five years ago was worth $1,150 at the close on October 30, 2026, with dividends reinvested: an average return of 2.8% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +3.6% | — | $1,036 | -0.9% |
| 3 months | -35.1% | — | $648.66 | +2.1% |
| Year to date | -14.7% | — | $853.27 | +11.7% |
| 1 year | -29.1% | — | $708.70 | +12.4% |
| 3 years | +128.0% | +31.6% | $2,280 | +88.5% |
| 5 years | +15.0% | +2.8% | $1,150 | +76.0% |
Dyne Therapeutics return by calendar year
| Year | DYN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -14.7% | +11.7% | -26.4% |
| 2025 | -17.0% | +17.7% | -34.7% |
| 2024 | +77.1% | +24.9% | +52.3% |
| 2023 | +14.8% | +26.2% | -11.4% |
| 2022 | -2.5% | -18.2% | +15.6% |
| 2021 | -43.4% | +28.7% | -72.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Dyne Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.